[PRLD] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[PRLD] Prelude Therapeutics Incorporated
Announcement Date
15-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -8.06%
YoY- -57.60%
Quarter Report
PRLD's Result
PRLD's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 3,000 0 0 3,424 0 0 0 -
PBT -32,271 -34,740 -31,431 -33,075 -30,608 -30,431 -27,718 10.64%
Tax 0 0 -426 1,676 -279 239 -1,397 -
NP -32,271 -34,740 -31,431 -33,075 -30,608 -30,431 -26,321 14.51%
Tax Rate - - - - - - - -
Total Cost 35,271 34,740 31,431 36,499 30,608 30,431 26,321 21.48%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -1,075.70 0.00 0.00 -965.98 0.00 0.00 0.00 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.43 -0.46 -0.42 -0.48 -0.45 -0.54 -0.55 -15.09%
EPS Diluted -0.43 -0.46 -0.42 -0.48 -0.45 -0.54 -0.55 -15.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.